SynHealth: Funded by the European Commission’s Horizon Europe Programme, the project leverages AI and multi-agent systems to valorise the potential of glycan biomarkers and adopt them for personalized preventive healthcare
Opening a 36-month project
Last April, SynHealth gather consortiums partners for its kickoff meeting. 7 partners from 5 European countries marked the opening of the 3-year project, aimed at revolutionising the European healthcare ecosystem.
It set the first stone to the main objectives that will be completed through the programme:
- Develop person-centered AI based support tools to enable scalability of GlycanAge personalized counseling
- Prepare clinical study for glycan biomarkers for personalized preventive medicine
- Demonstrate adoption of glycan biomarkers for personalized preventive healthcare in a real world setting and create the network of partners in the region
- Improve capacity for innovation, IP management and knowledge transfer
- Maximize the impact of the project through a dedicated communication, dissemination and exploitation strategy
The project is led by a multiskilled team comprised of coordinator Genos, and partners: GlycanAge, University of Maribor, University of Liege, Karolinska Institute and F6S.
Follow SynHealth’s journey and don’t miss the new developments and upcoming results!
Visit the project website: https://synhealth-project.eu/
LinkedIn: https://www.linkedin.com/company/synhealth/
Twitter: https://x.com/synhealth_eu